Core Catalyst Makes Eastman a Premier Payout Safe Haven
Eastman Chemical is delivering a steady 4.5% dividend as a new core catalyst reshapes its cash flow, turning the comp...
We compare the 2024 outlook for index funds and target date funds to help you choose the right retirement path.
23,982 articlesEastman Chemical is delivering a steady 4.5% dividend as a new core catalyst reshapes its cash flow, turning the comp...
As markets bounce between frenzy and caution, investors are weighing two paths: a focused bet on seven mega-cap names...
Dragonfly Capital closes a $650 million fund to back early-stage crypto ventures as liquidity tightens and token pric...
A hedge fund made a sizable new bet on Centuri Holdings, disclosed in an SEC filing. This article breaks down the num...
When a prominent fund makes a sizable stake reduction, it often signals more than profit-taking. This article breaks ...
A niche bond ETF focused on mid-tier CLO tranches is drawing buyers as rate expectations stay elevated. The fund aims...
Two popular international ETFs, EEM and IXUS, suit different goals. This guide explains how EEM offers focused growth...
Buffett’s retirement signals a new chapter for Berkshire Hathaway. Discover why move over, apple: berkshire could bec...
A hypothetical hawkish turn from chair Kevin Warsh sends ripples through markets. This guide explains what it means f...
Smart investing in 2026 starts with clear rules. Here are seven practical guidelines, illustrated with Nvidia, Palant...
A viral AI video about a famed athlete sparked more than headlines—it spotlighted money risks and smart financial hab...
A major fund recently trimmed its stake in Viridian Therapeutics, signaling potential rotation rather than a verdict ...